Ciprofloxacin: Clinical Trials

272 trials of Ciprofloxacin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

172 completed, 30 terminated, 22 recruiting, 22 unknown. 68 Phase 4, 58 Phase 3, 55 Phase 2, 44 Phase 1, 40 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 468Completed 41, Recruiting 7, Withdrawn 7, Terminated 6, Unknown 5, Not yet recruiting 2
Phase 358Completed 37, Terminated 10, Recruiting 4, Unknown 4, Withdrawn 3
Phase 255Completed 31, Recruiting 8, Terminated 8, Unknown 4, Not yet recruiting 2, Withdrawn 2
Phase 144Completed 33, Terminated 3, Recruiting 2, Unknown 2, Withdrawn 2, Active not recruiting 1, Suspended 1
Not applicable40Completed 19, Unknown 8, Terminated 5, Recruiting 4, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1
Early Phase 17Completed 3, Active not recruiting 2, Terminated 1, Unknown 1

Follow Ciprofloxacin: new trials by email Literature Review of Ciprofloxacin trials Research Report on Ciprofloxacin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM)
Phase 2Not yet recruitingZealand University Hospital1502027-03-012026-09-25
Antibiotics After Incision and Drainage to Prevent Fistula Formation After First Episode of Perianal Abscess
Amoxicillin + Clavulanate, Ciprofloxacin + Metronidazole - Perianal Abscess, Anal Fistula
Phase 4Not yet recruitingUniversity of Illinois at Chicago2362026-10-052026-09-21
Acetic Acid Ear Drops Versus 0.3 % Ciprofloxacin for Chronic Suppurative Otitis Media.
Acetic Acid 2% Ear Drops, Ciprofloxacin 0.3% Otic Solution - Otitis Media Chronic
Not applicableNot yet recruitingDow University of Health Sciences1462026-09-232026-09-22
Prophylactic Antibiotics for Outpatient Urethral Bulking
Bactrim (800/160 mg), Keflex (500 mg), Cipro (250 mg), or Macrobid (100mg) - Urinary Tract Infections, Stress Urinary Incontinence
Phase 4RecruitingUniversity of Miami1502026-08-012026-08-20
Non-antibiotic Management in Acute Uncomplicated Diverticulitis
Symptomatic treatment (ibuprofen and acetaminophen), Amoxicillin-clavulanate, Ciprofloxacin plus metronidazole - Acute Uncomplicated Diverticulitis
Phase 4WithdrawnMontefiore Medical Center2026-07-012026-08-31
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer
Phase 4Not yet recruitingHospital Universitari Vall d'Hebron Research Institute1362026-06-012026-05-15
PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment
Nal-IRI, Ciprofloxacin, Paclitaxel - PDAC - Pancreatic Ductal Adenocarcinoma
Phase 2Not yet recruitingGERCOR - Multidisciplinary Oncology Cooperative Group2062025-07-012025-07-01
Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair
Conventional double antibiotic paste of Metronidazole 500 mg plus Ciprofloxacin 500 mg mixed with propylene glycol, Double antibiotic paste of Metronidazole and Ciprofloxacin loaded chitosan-coated silver nanoparticles, chitosan-coated silver nanoparticles - Pain, Postoperative, Root Resorption
Not applicableEnrolling by invitationAin Shams University1082025-07-012026-09-29
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Ceftazidime, Ciprofloxacin - Neutropenic Fever, Acute Lymphoblastic Leukemia
Phase 4RecruitingGadjah Mada University1202025-06-012025-08-22
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Intravenous immunoglobulin, Trimethoprim / Sulfamethoxazole, Amoxicillin clavulanic acid - Myeloma, Non-Hodgkin's Lymphoma
Phase 2 / Phase 3RecruitingMonash University9002025-05-062025-10-07
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Trimethoprim Sulfamethoxazole, Amoxycillin/clavulanic acid, Immune Globulin Intravenous - Myeloma, Leukemia
Phase 2 / Phase 3RecruitingMonash University9002025-05-062025-10-07
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin - Colorectal Cancer, CRC
Phase 2RecruitingVirginia Commonwealth University972025-03-072026-08-18
Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever
Levofloxacin, ciprofloxacin - Typhoid, Fever
Phase 2CompletedAvicenna Medical College Lahore3602025-02-072025-09-02
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
Ciprofloxacin (BAYO9867), sodium stibogluconate (Pentostam) - Cutaneous Leishmaniasis
Phase 2RecruitingAl-Mustafa University College802025-02-072025-09-30
Antibiotic Prophylaxis for Neurogenic Bladder Botox
Ciprofloxacin, Placebo - Neurogenic Bladder, Post-operative Urinary Tract Infections
Phase 2RecruitingUniversity of Alberta1602025-02-012026-05-07
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Shigella sonnei 53G, Ciprofloxacin 500 mg - Shigellosis
Phase 1RecruitingUniversity of Oxford702025-01-212025-03-13
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
Pivmecillinam, Amoxicillin clavulanic acid, Amoxicillin - Cystectomy, Bladder Cancer Requiring Cystectomy
Phase 4RecruitingCopenhagen University Hospital, Rigshospitalet2482025-01-072025-01-09
Glycemia and Antibiotic Efficacy in Diabetic Recurrent UTIs
ciprofloxacin 500 mg tablet - T2DM (Type 2 Diabetes Mellitus)
Not applicableCompletedAl-Mustansiriyah University992024-10-302025-09-24
Comparing the Effect of Different Intracanal Dressing on Failed Root Canal Treated Cases on Periapical Healing
nanocurcumin gel, Curcumin Gel, Ciprofloxacin 500 mg +ibuprofen 400mg - Periapical Disease
Phase 2CompletedAin Shams University602024-06-202025-11-17
Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
WCK 4282 (FEP-TAZ) 4 g, Meropenem, ciprofloxacin 500 mg Optional Oral Switch - Complicated Urinary Tract Infection, Acute Pyelonephritis
Phase 3UnknownWockhardt10042024-01-012023-07-17

Showing 20 of 272. Sign in to see all of them.

Conditions studied

Urinary Tract Infections (24)  ·  Infections (17)  ·  Crohn Disease (8)  ·  Pulmonary Disease, Chronic Obstructive (8)  ·  Anthrax (7)  ·  Cystic Fibrosis (7)  ·  Neoplasms (7)  ·  Otitis (7)  ·  Otitis Externa (7)  ·  Pneumonia (7)  ·  Sepsis (7)  ·  Bacterial Infections (6)  ·  Febrile Neutropenia (6)  ·  Fever (6)  ·  Lymphoma (6)

Sponsors

Bayer (21)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Otonomy, Inc. (5)  ·  Iterum Therapeutics, International Limited (4)  ·  Ain Shams University (3)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Monash University (3)  ·  Otic Pharma (3)  ·  Poitiers University Hospital (3)  ·  Radboud University Medical Center (3)  ·  University of Chicago (3)  ·  University of North Carolina, Chapel Hill (3)  ·  University of Washington (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Alcon Research (2)

Countries

United States (100)  ·  Canada (23)  ·  Germany (15)  ·  Spain (15)  ·  United Kingdom (15)  ·  Netherlands (14)  ·  France (13)  ·  Egypt (12)  ·  Israel (11)  ·  Australia (9)  ·  Brazil (8)  ·  Denmark (8)  ·  Italy (8)  ·  Japan (7)  ·  South Korea (7)

Top investigators

Carl LeBel, PhD (4)  ·  Yehudah Roth, MD (3)  ·  Lindsey Albenberg, DO (2)  ·  Paul Newell, MBBS, MRCP (2)  ·  Zoe McQuilten, Professor (2)  ·  A. Hillary Steinhart, M.D. (1)  ·  Aggelos Pefanis (1)  ·  Agricio N. Crespo, Phd (1)  ·  Ahmed A Elberry, professor (1)  ·  Ahmed AbdelAleem, PhD (1)  ·  Ahmed Dr El Kased, PhD (1)

Results publications

PMID 23317527, PMID 27313268, PMID 29339393, PMID 29912399, PMID 30061279, PMID 30221827, PMID 32602065, PMID 10798549, PMID 11448564, PMID 14557966, PMID 14986270, PMID 15276398, PMID 15329363, PMID 15770833, PMID 15840453, PMID 16182896, PMID 16982292, PMID 17192170, PMID 17574960, PMID 17854593, PMID 18211932, PMID 18702902, PMID 18818959, PMID 19128645, PMID 19146007, PMID 19234342, PMID 19501498, PMID 19563257, PMID 19588358, PMID 19821321, PMID 20151809, PMID 20176900, PMID 20231680, PMID 20383102, PMID 20536364, PMID 20675299, PMID 21129208, PMID 21394050, PMID 21410904, PMID 21453653, PMID 21837771, PMID 21893650, PMID 21994333, PMID 22157324, PMID 22271702, PMID 22311838, PMID 22318279, PMID 22421690, PMID 2246576, PMID 22530208

NIH funding

2008 (4), 2014 (4), 2005 (1), 2009 (1), 2015 (1), 2016 (1), 2017 (1), 2019 (1), 2025 (1), K23DK109136 (1), P30CA012197 (1), R21DE023046 (1), U01AI162457 (1), U01DK065209 (1), U01HL080310 (1)